{"DataElement":{"publicId":"7642165","version":"1","preferredName":"Surgical Margins Assessment Melanoma Status","preferredDefinition":"A status to indicate whether the presence of actual or potential neoplastic tissue has been left outside the boundary of a resected specimen of the skin (cutaneous melanomas), other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system, or in metastasized lymph nodes, liver, lungs, and brain sites.","longName":"7642156v1.0:7642159v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7642156","version":"1","preferredName":"Surgical Margins Status Assessment","preferredDefinition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient._The final result of a determination of the value, significance, or extent of.","longName":"7642154v1.0:2465182v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7642154","version":"1","preferredName":"Surgical Margins Status","preferredDefinition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","longName":"C123560","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Margins Status","conceptCode":"C123560","definition":"The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E1EAB3-3ED4-6E7C-E053-4EBD850ADE2C","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E1EAB3-3EE2-6E7C-E053-4EBD850ADE2C","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":null,"administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7642159","version":"1","preferredName":"Melanoma Status","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain._A condition or state at a particular time.","longName":"7642159v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Margin(s) involved by invasive melanoma","valueDescription":"Margin Involved by Invasive Melanoma","ValueMeaning":{"publicId":"7642863","version":"1","preferredName":"Margin Involved by Invasive Melanoma","longName":"7642863","preferredDefinition":"A result that the margin is involved by invasive melanoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin Involved by Invasive Melanoma","conceptCode":"C159232","definition":"A result that the margin is involved by invasive melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E5FE3B-F439-2E6F-E053-4EBD850A7AE5","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E5FE3B-F452-2E6F-E053-4EBD850A7AE5","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"Cannot be assessed","valueDescription":"Margin Status Cannot be Assessed","ValueMeaning":{"publicId":"7642164","version":"1","preferredName":"Margin Status Cannot be Assessed","longName":"7642164","preferredDefinition":"A result that the margin status cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin Status Cannot be Assessed","conceptCode":"C160705","definition":"A result that the margin status cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E20D99-4F2D-2874-E053-4EBD850ACE1D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2227944-C78D-7D5E-E053-4EBD850A996D","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"},{"value":"Margins uninvolved by invasive melanoma","valueDescription":"Margin Uninvolved by Invasive Melanoma","ValueMeaning":{"publicId":"7642162","version":"1","preferredName":"Margin Uninvolved by Invasive Melanoma","longName":"7642162","preferredDefinition":"A result that the margin is uninvolved by invasive melanoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Margin Uninvolved by Invasive Melanoma","conceptCode":"C159409","definition":"A result that the margin is uninvolved by invasive melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E20D99-4F07-2874-E053-4EBD850ACE1D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C2227944-C7A1-7D5E-E053-4EBD850A996D","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7642158","version":"1","preferredName":"Melanoma Status","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.:A condition or state at a particular time.","longName":"C3224:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E20D99-4EB9-2874-E053-4EBD850ACE1D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Historical","id":"C0E20D99-4ECA-2874-E053-4EBD850ACE1D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Margin Status","type":"Preferred Question Text","description":"Margin Status","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C0E2309A-1F38-4C01-E053-4EBD850A1F1D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-08","changeDescription":"6/22/21 jk upd sys gen def. 4/26/21 ls created for CM CRF.","administrativeNotes":"9/8/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}